Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 4, 2018
Erratum
Michelle A Erickson, Joseph Jude, Hengjiang Zhao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 24, 2017
Serum amyloid A: an ozone-induced circulating factor with potentially important functions in the lung-brain axis
Michelle A Erickson, Joseph Jude, Hengjiang Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 30, 2022
Transport of the Proinflammatory Chemokines C-C Motif Chemokine Ligand 2 (MCP-1) and C-C Motif Chemokine Ligand 5 (RANTES) across the Intact Mouse Blood-Brain Barrier Is Inhibited by Heparin and Eprodisate and Increased with Systemic Inflammation
Daniel V Quaranta, Riley R Weaver, Kristen K Baumann, et al.
Brain, Behavior, and Immunity
|
June 3, 2009
Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease
Laura B Jaeger, Shinya Dohgu, Rukhsana Sultana, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 7, 2024
Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model
Emily Z Huie, Xin Yang, Mengia S Rioult-Pedotti, et al.
Journal of Neuropathology and Experimental Neurology
|
October 16, 2015
Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders
Brigid K Jensen, Hubert Monnerie, Maggie V Mannell, et al.
Brain, Behavior, and Immunity
|
January 22, 2023
Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer's disease
Michelle A Erickson, Aric F Logsdon, Elizabeth M Rhea, et al.
The American Journal of Pathology
|
December 21, 2016
HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation
Patrick J Gannon, Cagla Akay-Espinoza, Alan C Yee, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 4, 2018
Erratum
Michelle A Erickson, Joseph Jude, Hengjiang Zhao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 24, 2017
Serum amyloid A: an ozone-induced circulating factor with potentially important functions in the lung-brain axis
Michelle A Erickson, Joseph Jude, Hengjiang Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 30, 2022
Transport of the Proinflammatory Chemokines C-C Motif Chemokine Ligand 2 (MCP-1) and C-C Motif Chemokine Ligand 5 (RANTES) across the Intact Mouse Blood-Brain Barrier Is Inhibited by Heparin and Eprodisate and Increased with Systemic Inflammation
Daniel V Quaranta, Riley R Weaver, Kristen K Baumann, et al.
Brain, Behavior, and Immunity
|
June 3, 2009
Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease
Laura B Jaeger, Shinya Dohgu, Rukhsana Sultana, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 7, 2024
Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model
Emily Z Huie, Xin Yang, Mengia S Rioult-Pedotti, et al.
Journal of Neuropathology and Experimental Neurology
|
October 16, 2015
Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders
Brigid K Jensen, Hubert Monnerie, Maggie V Mannell, et al.
Brain, Behavior, and Immunity
|
January 22, 2023
Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer's disease
Michelle A Erickson, Aric F Logsdon, Elizabeth M Rhea, et al.
The American Journal of Pathology
|
December 21, 2016
HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation
Patrick J Gannon, Cagla Akay-Espinoza, Alan C Yee, et al.
Page
of 7